Allspring Global Investments Holdings LLC Boosts Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• Allspring Global Investments increased its stake in Omega Healthcare Investors by 5.6% (an additional 47,807 shares) to 903,525 shares, representing about a 0.31% ownership stake worth roughly $40.23 million.
• Omega recently paid a quarterly dividend of $0.67 (annualized $2.68) for a 6.0% yield, though the payout ratio is high at 138.86%.
• Analysts' consensus is a "Moderate Buy" with a $48 target price; the stock has a $13.31 billion market cap and about 65.25% of shares are held by institutional investors.

Allspring Global Investments Holdings LLC increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 5.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 903,525 shares of the real estate investment trust's stock after purchasing an additional 47,807 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.31% of Omega Healthcare Investors worth $40,234,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Omega Healthcare Investors by 3.4% in the third quarter. Vanguard Group Inc. now owns 42,152,368 shares of the real estate investment trust's stock worth $1,779,673,000 after buying an additional 1,386,887 shares during the last quarter. State Street Corp lifted its position in Omega Healthcare Investors by 4.8% in the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust's stock valued at $534,792,000 after acquiring an additional 671,473 shares in the last quarter. Invesco Ltd. boosted its stake in Omega Healthcare Investors by 101.7% during the 3rd quarter. Invesco Ltd. now owns 4,944,921 shares of the real estate investment trust's stock valued at $208,775,000 after purchasing an additional 2,493,877 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Omega Healthcare Investors by 2.6% during the 3rd quarter. Dimensional Fund Advisors LP now owns 4,211,183 shares of the real estate investment trust's stock valued at $177,790,000 after purchasing an additional 107,843 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its holdings in shares of Omega Healthcare Investors by 6.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 3,761,216 shares of the real estate investment trust's stock worth $158,799,000 after purchasing an additional 239,134 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Stock Up 1.5%

Omega Healthcare Investors stock opened at $45.02 on Friday. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $49.14. The stock has a fifty day moving average of $45.97 and a 200 day moving average of $44.15. The company has a debt-to-equity ratio of 0.78, a quick ratio of 5.04 and a current ratio of 5.04. The stock has a market cap of $13.31 billion, a PE ratio of 23.32, a price-to-earnings-growth ratio of 1.88 and a beta of 0.59.

Omega Healthcare Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Monday, February 9th were paid a dividend of $0.67 per share. The ex-dividend date was Monday, February 9th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.0%. Omega Healthcare Investors's payout ratio is 138.86%.

Analyst Ratings Changes

Several research firms recently commented on OHI. Truist Financial lifted their price objective on Omega Healthcare Investors from $46.00 to $48.00 and gave the stock a "hold" rating in a report on Thursday, March 5th. UBS Group restated a "buy" rating and set a $52.00 target price on shares of Omega Healthcare Investors in a research note on Friday, February 6th. Royal Bank Of Canada lifted their price target on shares of Omega Healthcare Investors from $44.00 to $47.00 and gave the stock a "sector perform" rating in a research note on Tuesday, February 10th. Jefferies Financial Group reissued a "hold" rating and set a $45.00 price objective on shares of Omega Healthcare Investors in a report on Monday, December 15th. Finally, Scotiabank increased their price objective on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company a "sector perform" rating in a research report on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Omega Healthcare Investors has an average rating of "Moderate Buy" and a consensus target price of $48.00.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.